Sector
PharmaceuticalsOpen
₹240Prev. Close
₹241.37Turnover(Lac.)
₹48.54Day's High
₹248.89Day's Low
₹238.0252 Week's High
₹32552 Week's Low
₹178Book Value
₹69.68Face Value
₹10Mkt Cap (₹ Cr.)
294.23P/E
20.49EPS
11.78Divi. Yield
017 Aug 2023
12:00 AM
AGM
Announcement Date: 17 Aug, 2023
17 Aug 2023
12:00 AM
BookCloser
29 Apr 2024
12:00 AM
Board Meeting
Agenda : Audited Result
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 12.3 | 12.3 | 6.15 | 6.15 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 58.93 | 47.57 | 46.06 | 34.46 |
Net Worth | 71.23 | 59.87 | 52.21 | 40.61 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Revenue | 60.75 | 55.84 | 48.76 |
yoy growth (%) | 8.77 | 14.52 | |
Raw materials | -21.87 | -23.65 | -21.06 |
As % of sales | 36.01 | 42.35 | 43.2 |
Employee costs | -3.97 | -4.11 | -3.18 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Profit before tax | 12.74 | 5.99 | 3.26 |
Depreciation | -2.81 | -2.76 | -2.81 |
Tax paid | -3.11 | -1.22 | -1.51 |
Working capital | 14.37 | 10.27 | |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2017 |
|---|---|---|---|
Growth matrix (%) | |||
Revenue growth | 8.77 | 14.52 | |
Op profit growth | 69.47 | 10.59 | |
EBIT growth | 97.21 | 17.67 | |
Net profit growth | 143.67 | 171.62 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director
FALGUN VALLABHBHAI SAVANI
Executive Director & CEO
JIGNESHBHAI VALLABHBHAI SAVANI
WTD & Executive Director
GHANSHAYAMBHAI BHAGVANBHAI SAVANI
Non Executive Director
Nayna Jignesh Savani
Independent Non Exe. Director
Krishna Mitulbhai Shah
Independent Non Exe. Director
Kajal Chintanbhai Vaghani
Independent Non Exe. Director
Pravin Manjibhai Bhayani
Independent Non Exe. Director
Bintal Bhaveshkumar Shah
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Par Drugs & Chemicals Ltd
Summary
Par Drugs and Chemicals Limited was originally incorporated as a private limited company with the name Par Drugs and Chemicals Private Limited at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the company was converted into a public limited company pursuant to special resolution passed by the members in extra-ordinary general meeting of the company held on October 24, 2018 and the name of the company was changed to Par Drugs and Chemicals Limited on 5 November 2018.Vallabhbhai Savani and Sarita Savani were initial subscribers to the Memorandum of Association of the company. The Promoters of the company are Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani. The Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani have first shares on 19, 2006 through allotment of shares by company.The Company is engaged in the development and manufacture of Active Pharma ingredients (APIs) for the domestic market as well as for exports to international markets. APIs, also known as bulk drugs or bulk actives are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company produce various range of Antacid Molecules which are available in the market and are in great demand.The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facilit
Read More
What is the Par Drugs & Chemicals Ltd share price today?
The Par Drugs & Chemicals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹239.12 today.
What is the Market Cap of Par Drugs & Chemicals Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Par Drugs & Chemicals Ltd is ₹294.23 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Par Drugs & Chemicals Ltd?
The PE and PB ratios of Par Drugs & Chemicals Ltd is 20.49 and 3.47 as of 22 Jul ‘24
What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?
The 52-week high/low is the highest and lowest price at which a Par Drugs & Chemicals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Par Drugs & Chemicals Ltd is ₹178 and ₹325 as of 22 Jul ‘24
What is the CAGR of Par Drugs & Chemicals Ltd?
Par Drugs & Chemicals Ltd's CAGR for 5 Years at 56.05%, 3 Years at 23.90%, 1 Year at 24.64%, 6 Month at 15.63%, 3 Month at -13.36% and 1 Month at 7.59%.
What is the shareholding pattern of Par Drugs & Chemicals Ltd?
The shareholding pattern of Par Drugs & Chemicals Ltd is as follows:
Promoters - 74.21 %
Institutions - 0.11 %
Public - 25.68 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
